4//SEC Filing
Gleason Shane Thomas 4
Accession 0001493152-23-018337
CIK 0001433607other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:15 PM ET
Size
17.6 KB
Accession
0001493152-23-018337
Insider Transaction Report
Form 4
InspireMD, Inc.NSPR
Gleason Shane Thomas
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-05-17+256,450→ 256,450 total - Award
Options to purchase common stock (right to buy)
2023-05-17+85,480→ 85,480 totalExercise: $1.76Exp: 2033-05-17→ Common Stock (85,480 underlying)
Footnotes (2)
- [F1]These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.
- [F2]The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.
Documents
Issuer
InspireMD, Inc.
CIK 0001433607
Entity typeother
Related Parties
1- filerCIK 0001966214
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:15 PM ET
- Size
- 17.6 KB